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I. Preamble
The mission of the American College of Cardiology (ACC) is
to foster optimal cardiovascular care through professional
education, promotion of research, leadership in the develop-
ment of standards and guidelines and the formulation of health
care policy. Coronary angioplasty and other coronary interven-
tional procedures are frequently performed therapeutic tech-
niques for cardiac revascularization. In keeping with its mis-
sion, the College has a responsibility to develop standards for
the performance of coronary interventional procedures that
will assure the public of the availability of uniformly high
quality services. This document has been developed for that
purpose. It compiles and reviews the current scientific knowl-
edge base and applies it to guidelines intended to optimize the
quality of coronary interventional procedures.
This document addresses the issue of assessment and
maintenance of proficiency both for individual physician-
operators and for the institutions in which coronary interven-
tional procedures are performed. This issue of training re-
quirements will be addressed in a subsequent document.
II. Executive Summary
Purpose and Goals
The mission of the ACC is to foster optimal quality
cardiovascular care through professional education, promotion
of research, leadership in the development of standards and
guidelines and the formulation of health care policy. This
document compiles and reviews the current coronary angio-
plasty knowledge base and applies it to guidelines intended to
optimize the quality of coronary interventional procedures. It
addresses the issue of maintenance of proficiency both for
individual physician-operators and for the institutions in which
coronary interventional procedures are performed. The issue
of training requirements will be addressed in a subsequent
document.
This document was developed to review the currently
available scientific data with the following purposes:
1. To characterize the expected success and complication rates
for coronary interventional procedures.
2. To identify comorbidities and other risk factors that may be
used for risk adjustment when assessing particular success
and complication rates.
3. To study the relation between operator and institutional
activity level and proficiency in coronary interventional
procedures.
4. To develop recommendations for standards to assess oper-
ator proficiency and institutional programmatic quality.
Background
Professional organizations have addressed the issue of
standards and criteria for competence in coronary angioplasty
since 1986, with an increasing focus on the issue of mainte-
nance of competence and skills. These documents have uni-
versally endorsed an annual operator case load standard, most
commonly 75 procedures/year, as a threshold value for main-
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tenance of competence. This figure exceeds the median annual
case load of physicians practicing interventional cardiology in
the United States. The ACC’s current position on these issues,
which also advocates the 75-procedure/year standard, was
published in 1993. Until recently, few published statistical data
were available to assess the validity of such recommendations.
As a consequence, these positions have been controversial.
Recently, multiple publications analyzing large datasets have
examined this relation, making a reexamination of the issue
timely and appropriate.
Evolution of Coronary Angioplasty Techniques
The capability and, concomitantly, the cognitive and tech-
nical knowledge base of coronary angioplasty has also ex-
panded. As a result, success rates for coronary angioplasty
have progressively improved despite an increase in procedural
difficulty. In the past 5 years multiple non-balloon devices and
adjunctive antithrombotic medications that augment and ex-
tend the capability of conventional balloon angioplasty have
been introduced. To use these new interventional devices and
medications effectively, an operator must acquire an additional
cognitive knowledge base and master the additional technical
skills. These and other changing factors have placed additional
cognitive and technical demands on physician-operators while
improving the overall success and complication rates of coro-
nary interventional procedures. They have led to the extension
of interventional treatment to higher risk patients with more
complex coronary anatomy and comorbid disease.
The institution in which interventional procedures are
performed has an important impact on procedural success.
The physical facility must provide optimal radiologic, monitor-
ing and patient support equipment to enable operators to
perform at the best of their ability. An extensive support
system of specifically trained laboratory personnel and imme-
diately available cardiothoracic surgical, respiratory and anes-
thesia services is essential to respond to emergency situations
to minimize their detrimental outcomes. In addition, the
institution through its systems of credentialling, governance,
data gathering and quality assessment monitoring provides
important quality control over the entire interventional pro-
gram.
The number of non-balloon devices is increasing, and they
are often more demanding to use than conventional balloon
technology and are often used in patients with more complex
and riskier clinical circumstances. Consequently, proficiency in
the use of these devices is device specific and must be
differentiated from proficiency in conventional balloon angio-
plasty. The goals in using these devices must be kept in mind
because they are most often used as an adjunct to conventional
balloon angioplasty.
There are three groups of devices:
1. Devices that are used to extend the capability of conven-
tional balloon angioplasty. Not all interventional cardiolo-
gists need to know how to use all the devices in this group
because these devices is used electively, with advance
planning. Thus, the experience with these devices should be
concentrated within each laboratory.
2. Devices used to treat complications of interventional pro-
cedures. The most common devices in this group are stents
for treatment of abrupt or threatened closure. Every inter-
ventional cardiologist should be trained and certified in
rescue stenting.
3. Devices used to prevent restenosis. This group of devices is
limited to stents and directional coronary atherectomy
(DCA), with stents being used most frequently.
Data Relating Operator and Institutional
Experience and Activity to Outcome in Coronary
Interventional Procedures
Computerized literature searches of English language pub-
lications, review of recent abstract publications and solicitation
of manuscripts under review for publication from many physi-
cians and epidemiologists expert in the field were used to
compile the relevant available scientific evidence relating
operator and institutional activity level to outcomes.
Evaluation of the quality of individual lower volume hospi-
tals and individual practitioners is limited by the wide confi-
dence intervals around an estimate of risk of complications
arising simply from the relatively few procedures from which to
draw conclusions. This issue is more marked for individual
practitioners whose annual procedural volumes are low com-
pared with institutional volumes and is most marked for the
lowest volume practitioners about whom the most questions
concerning proficiency exist. This statistical power issue pre-
sents a major problem when attempting to make valid judg-
ments of the quality of low volume programs and operators.
Relation of Institutional and Operator Procedural
Volume to Procedural Outcome
The preponderance of data suggest that, on average, hos-
pitals in which fewer procedures are performed have a greater
incidence of complications, notably death and need for bypass
surgery for failed intervention, than do hospitals in which more
procedures are performed. Multiple data sources support the
existence of a curvilinear, perhaps logarithmic, statistical rela-
tion between caseload and outcome. The existence of this
relation is most persuasively supported by the concordance of
results from multiple sources, including the Society for Cardiac
Angiography and Interventions and the most recent Medicare
and New York State experiences. Consequently, concerns have
been raised regarding the results of coronary interventions
performed in hospitals with an annual volume of ,200 to 400
cases/year.
However, procedural volume is only one of many factors
contributing to the variability of measured outcomes. For an
individual institution, however, such an impression must be
tempered by the statistical imprecision of the estimate of risk.
Furthermore, there is no clear “cutoff” above or below which
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hospitals, or groups of hospitals in aggregate, perform well or
poorly. There are institutions with low volumes that appear to
achieve very acceptable results.
The same large data sets support the contention that there
is, on average, an inverse relation between an individual
operator’s annual caseload and likelihood of complications.
However, because of statistical power considerations, interpre-
tation of these data is more difficult and complex than for
hospital volume and outcome. The most compelling data that
support a relation between volume and outcome come from
the large, recently published analyses of the 1992 national
Medicare experience and the 1991 to 1994 New York State
experience. Both of these studies show a statistically signifi-
cant, albeit modest, inverse relation, with the risk of death and
emergency coronary artery bypass graft surgery (CABG) in-
creasing as caseload falls below 75 to 100 cases/year.
Consequently, it appears highly likely that there is a statis-
tical relation between individual operator procedural volume
and outcome, such that lower volume operators tend to
achieve less satisfactory results than higher volume operators.
However, this relation is not universal. There are operators
with annual caseloads lower than the previously defined ACC
requirement for maintenance of competency of at least 75
cases/year who appear to achieve acceptable results.
The relation between individual operator volume and out-
come is confounded by the fact that there may be an interac-
tion between physician and hospital volume, such that results
of lower volume operators in high volume institutions are
generally more favorable than those achieved by low volume
operators in low volume institutions.
Conclusions and Recommendations
General issues related to quality assessment. The current
interventional cardiology information base permits a number
of broad general conclusions. Some are based on published
statistical data; others are, by necessity, based on reasoned
judgments:
1. Coronary interventional procedures are complex and
technically demanding to perform. Optimal performance of
these procedures requires an extensive cognitive knowledge
base and substantial technical skill.
2. Complications of coronary interventional procedures,
which may be life threatening, sometimes occur unpredictably.
Optimal patient outcome, once a complication occurs, depends
on proper recognition and management.
3. The most recently compiled comprehensive statistical
data set (New York State 1991–1994) found overall death and
emergency CABG rates for all types of coronary interventional
procedures in all circumstances to be 0.9% and 3.0%, respec-
tively. There is ample reason to believe that complication rates
have decreased since those data were collected. Consequently,
these rates represent an absolute upper limit for benchmark
complication rates to be expected in a clinically stable popu-
lation.
4. There are consistent statistical associations between
operator and institutional activity levels and short-term com-
plication rates (emergency CABG and mortality). There is also
an interaction between the institutional program and the
operator activity level in determining complication rates. The
greatest complication rates occur when low volume operators
perform procedures at low volume institutions.
5. The differences in the absolute magnitude of complica-
tion rates between low and high volume institutions and
operators are small. In the New York State dataset, operators
performing ,75 procedures/year had mean mortality and
CABG rates of 1.0% and 3.9%, respectively, whereas higher
volume operators had mean mortality and CABG rates of
0.9% and 3.1%, respectively. That these differences are statis-
tically significant is due to the large sample size.
6. The low expected complication rate for coronary inter-
ventional procedures presents a major statistical power prob-
lem when attempting to estimate the true complication rate of
the low volume operator with statistically meaningful preci-
sion.
7. There are potential pitfalls in the use of complication
rates to judge operator proficiency. Such monitoring may affect
an operator’s case selection and judgment in a way that might
have an adverse impact on overall patient care.
Benchmark complication rates for quality standards. The
best subgroups of operators and institutions in the New York
State database achieved a mortality rate of 0.9% and an
emergency CABG rate of 3%. With appropriate qualifications,
these rates can serve as benchmark rates against which to judge
operators and programs.
It should be emphasized that these data are derived from all
percutaneous transluminal coronary angioplasty (PTCA) pro-
cedures, including those performed for acute myocardial in-
farction (MI) and cardiogenic shock. Thus, they overstate the
risk of complications in clinically stable patients undergoing
elective PTCA and understate the risk in high risk patients.
Furthermore, these data were gathered before stents and
platelet glycoprotein IIb/IIIa inhibitors were in widespread
use. It is likely that the availability of these treatments has
reduced the expected frequency of death and emergency
CABG.
Guidelines for institutions that offer coronary interven-
tional services. Institutions offering coronary interventional
services should meet the following standards:
1. Quality assessment monitoring. It is essential that an
institution have a rigorous privilege-granting and quality as-
sessment monitoring system in place to assess the quality and
efficacy of its overall program and its individual physician-
operators.
2. Institutional activity levels. An institution should have an
activity level of at least 400 coronary procedures/year. An
institution with a volume of ,200 procedures/year, unless in a
region that is underserved because of geography, should
carefully consider whether it should continue to offer the
service.
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3. Coronary interventional program director. An institution
offering coronary interventional services should have a
physician-director who is responsible for the program’s overall
quality. The director should be an experienced operator with a
career experience of .500 procedures and should perform
procedures at the facility that he or she directs. The director
should be certified in the commonly used adjunctive interven-
tional devices and should be certified in interventional cardi-
ology by the American Board of Internal Medicine (ABIM)
(once the ABIM Added Qualification Examination in Inter-
ventional Cardiology is in place).
4. Facility equipment and staff requirements. The facility
should provide an optimal physical and intellectual infrastruc-
ture to support procedures. Radiologic equipment must pro-
vide high resolution fluoroscopic imaging with digital video
processing to permit ready immediate review of high quality
cineradiographic images. The nursing, technical and physician
support staff must be experienced and able to respond readily
to emergency and other unusual situations.
Guidelines for physician-operators who perform coronary
interventional procedures. Physicians who perform coronary
interventional procedures should meet the following standards:
1. Quality assessment monitoring. A physician-operator’s
proficiency should ultimately be judged by his or her clinical
results. The procedural success and complication rates for all
physician-operators should be rigorously compiled and period-
ically reviewed. The overall performance of physicians whose
complication rates exceed the benchmark standards for any
period should be reviewed by the program director, with
careful attention to statistical power and risk adjustment
issues. Interpretation of complication rates must carefully
consider case-mix. Review of an operator’s performance
should be based on analysis of both current and cumulative
quality assessment statistics.
2. Operator activity levels. An operator should perform at
least 75 procedures/year to maintain optimal proficiency. Op-
erators who perform 50 to 75 procedures/year should be very
cautious in case selection. Their quality assessment statistics
should be carefully reviewed with respect to case selection and
outcome. Ideally, operators with an annual procedural volume
,75 should only work at institutions with an activity level .600
procedures/year.
3. Renewal of privileges. Granting and renewal of privileges
is the responsibility of the governance of the local health care
institution. The privileges of operators whose complication
rates exceed benchmark rates (currently 4% for combined
death and emergency CABG) should be reviewed carefully,
with particular attention to case-mix–based risk adjustment
and statistical power issues. Consideration should be given to
not renewing privileges if an operator’s complication rate
exceeds benchmark rates over a 2-year monitoring period.
4. Mentoring of operators. Operators who perform ,75
procedures/year should develop a defined mentoring relation-
ship with a highly experienced operator who has an annual
procedural volume .150 procedures/year. The purpose of this
relationship is to ensure that the operator’s patients can benefit
from the skills and knowledge of a more experienced physician
and to facilitate the operator’s acquisition of additional sophis-
tication and skills.
III. Introduction and Purpose
It is now over 20 years since Andreas Gruentzig performed
the first percutaneous coronary balloon angioplasty (PTCA)
(1,2). During this period, coronary angioplasty has evolved
from an investigational procedure to a widely practiced tech-
nique. In addition, several new non-balloon devices for coro-
nary intervention have received Food and Drug Administra-
tion approval and are currently in active clinical use. It is
estimated that in 1994, 428,000 coronary angioplasty proce-
dures were performed in the United States by ;6,100 physi-
cians (3). These physicians represent 40% of board-certified
cardiologists in the United States.
Coronary balloon angioplasty is a complex, demanding
procedure, and the newer non-balloon interventional devices
present additional technical and cognitive challenges. To per-
form coronary interventional procedures optimally, an opera-
tor must possess both considerable technical skill and a
substantial cognitive knowledge base. In addition, the technical
difficulty of a particular procedure varies considerably from
one patient to another. Consequently, as there can be variation
both among procedures in technical difficulty and among
operators in skill and cognitive knowledge, there is substantial
potential for variation in procedure safety and efficacy. In
addition, serious complications of coronary interventional pro-
cedures may occur unpredictably, even in procedures that
appear to be straightforward. Recognition and management of
complications is a complex discipline that requires skill, knowl-
edge, experience and judgment.
Now that the technique of coronary intervention has ma-
tured and its role in the management of coronary heart disease
has become clarified, there is a need for standards of profi-
ciency and quality.
Credentialing physicians to perform procedures is the re-
sponsibility of the governance of the local health care facility.
The Joint Commission on the Accreditation of Health Care
Organizations requires that medical staff privileges be granted
to applicants only after assessment based on professional
criteria. Physicians are charged with the responsibility to
establish the criteria that constitute professional competence
and to evaluate their peers on the basis of such criteria. The
U.S. health care system relies, in part, on this process of
granting and renewing clinical privileges to maintain quality.
The issue of determining quality standards and credential-
ing criteria for physician-operators to perform coronary inter-
ventional procedures has presented a major challenge to the
medical profession. The task of developing standards has been
difficult because, until recently, there were few data available
on which to base them and because coronary angioplasty
techniques, indications and capability have evolved rapidly.
During the past 9 years, a number of documents have been
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published that have offered guidelines and standards for
training and maintenance of competence (4–12). Because of
the paucity of clinical data, the earlier standards were devel-
oped principally through observation, experience and intuition.
These standards relied heavily on operator activity level as a
surrogate for skill and quality. They proposed minimal thresh-
old values both for training and experience and ongoing
activity levels. The activity level thresholds incorporated into
these standards were derived in part from the intuitive reason-
ing that to maintain skills and learn new techniques, an
operator must perform procedures at a requisite frequency.
The most recent document published by the ACC was
based on the information available in 1993 (6). The recom-
mendations of this and other similar documents have been
criticized as arbitrary and restrictive. This issue has great
significance because it is estimated that currently as many as
half of all physicians who perform coronary angioplasty have
activity levels below the current guideline threshold of 75
procedures/year (3).
The present document was developed to review the cur-
rently available scientific data with the following purposes:
1. To characterize the expected success and complication
rates for coronary interventional procedures when performed
by highly skilled operators. These expected rates may change
over time as instrumentation and technique improve and the
reservoir of highly skilled operators increases.
2. To identify comorbidities and other risk factors that may
be used for risk adjustment when assessing particular success
and complication rates.
3. To study the relation between operator activity level and
proficiency in coronary interventional procedures as assessed
by risk-adjusted outcome statistics.
4. To study the relation between institutional activity level
and success rates in coronary interventional procedures as
assessed by risk-adjusted outcome statistics.
5. To develop recommendations for standards to assess
operator proficiency and institutional program quality. These
include standards for data collection to permit monitoring of
effectiveness and appropriateness for coronary interventional
procedures both at the level of the operator and the institution.
IV. Method of Data Collection and Analysis
A. Writing Group Composition
The document writing group was selected to bring a broad
range of experience and expertise to bear on this issue. The
members of the writing group were identified on the basis of
one or more of the following attributes: highly experienced
coronary interventional operators; individuals who have done
clinical research studying the outcome of coronary interven-
tional procedures; individuals who direct catheterization labo-
ratories with a broad cross section of interventional operators;
and individuals with broad clinical experience who have had
considerable previous involvement with the issue.
B. Literature Review
A literature search was conducted with three goals:
1. To identify published coronary angioplasty outcomes
data that could be used as benchmarks for quality assessment.
In addition, the process sought to identify those risk adjust-
ment variables that affect the likelihood of success and com-
plications. Such variables can be used for modeling both
outcome and appropriateness. The review also focused on the
impact of the newer interventional devices other than conven-
tional balloon angioplasty.
2. To identify data that examine the relations between
operator experience and activity and procedural success and
complication rates.
3. To assess the issues and problems associated with judging
operator proficiency based on outcome statistics—in particu-
lar, the challenge of accurately assessing the low volume
operator’s performance.
V. Historical Background
A. Evolution of Competence and
Training Standards
Initially, because experience was limited, the coronary
angioplasty technique was disseminated informally among
physicians who were highly experienced at diagnostic cardiac
catheterization. During this period, physicians acquired angio-
plasty skills through “on the job” experience, and no standards
existed either for training requirements or for demonstration
of competence.
As the coronary angioplasty knowledge base grew and
techniques evolved, standards were developed for training.
Formal angioplasty training programs were first organized in
the early 1980s. Proposals for training standards were first
published in 1986 (4). The most recent recommendations were
published by the ACC in 1995 (11). The specialized nature of
coronary angioplasty was recognized by the ABIM in 1996 with
its decision to develop an Added Qualification Examination in
Interventional Cardiology.
Professional organizations have addressed the issue of
standards and criteria for proficiency in coronary angioplasty
since 1986, with an increasing focus on the issue of mainte-
nance of proficiency and skills (4–12). These documents have
universally endorsed an annual case load standard as a thresh-
old value for maintenance of proficiency. The most commonly
endorsed activity level has been 75 procedures/year, a figure
that exceeds the median annual case load of physicians prac-
ticing interventional cardiology in the United States. Until
recently, few published statistical data were available to assess
the validity of such recommendations. As a consequence, these
positions have been controversial.
Three issues have been raised concerning previously pub-
lished guidelines:
1. Volume is not absolutely related to quality.
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2. The numbers chosen have no solid basis.
3. If volume is the criterion, physicians with marginal numbers
will be prompted to alter case selection criteria to increase
their volume to satisfy requirements.
B. Evolution of Coronary Angioplasty Capabilities
Coronary angioplasty’s capability and, concomitantly, its
cognitive and technical knowledge base has also expanded.
The fundamental concepts of coronary angioplasty technique,
namely the coaxial guide catheter and the dilation catheter
with a minimally compliant cylindrical balloon were formu-
lated by Andreas Gruentzig (13). Initially, because of crude
equipment design and capability, coronary angioplasty was
only applicable to readily accessible discrete proximal coronary
stenoses. Subsequent instrumentation refinement has greatly
enhanced the technique’s capability and extended its indica-
tions. Complex anatomic situations now considered technically
suitable for coronary angioplasty include distal and bifurcation
stenoses; total occlusions (14); saphenous vein graft stenoses
(15); and geometrically complex stenoses, such as the ACC/
American Heart Association (AHA) lesion score (7) types B
and C. Challenging clinical situations now considered appro-
priate for coronary angioplasty include unstable angina
(16,17), acute MI (18,19) and high risk situations in which the
only remaining patent coronary vessel is treated.
In the past 5 years, other non-balloon devices, including
directional, rotational and laser atherectomy devices, and
coronary stents have been introduced. These devices augment
conventional balloon angioplasty and extend its capability. To
use any of the new interventional devices effectively, an
operator must acquire the additional cognitive knowledge base
and master the additional technical skills specific to that
device.
Recently, a number of adjunctive antithrombotic medica-
tions have been introduced for the purpose of reducing acute
thrombus-related lesion site complications. Understanding the
appropriate indications for and uses of these medications,
which are powerful anticoagulants, requires a specialized cog-
nitive knowledge of hemostatic mechanisms.
More recent clinical studies have demonstrated that despite
a further increase in clinical and angiographic complexity,
procedural and clinical success has remained high and compli-
cations low (Table 1) (20–24). Since the National Heart, Lung,
and Blood (NHLBI) II registry data were collected, the
average age has increased to .60 years, a higher percentage of
women now undergo the procedure, and the majority of
patients have unstable angina and multivessel coronary dis-
ease. Angiographic success (at least one lesion successfully
dilated by .20%, with a residual stenosis of ,50%) occurs in
nearly 90% of patients with an average mortality rate of 1%, a
Q wave MI rate of 1% to 2% and an emergency CABG rate of
1% to 6%. With the widespread use of coronary stents,
complications have fallen further, and emergency CABG
appears to be no greater than 1% to 2% currently. Thus, in
contemporary practice it should be expected that the overall
procedural success be at least 90%, clinical success at least
85%, death ,1%, Q wave MI ,1.5% and emergency CABG
,2%.
VI. Complications of Coronary
Interventional Procedures
An adverse event related to a coronary angioplasty proce-
dure may be categorized either by the mechanism of the
complication or by the adverse outcome event caused by it. A
given adverse event, such as death, may be caused by a variety
of complications.
Table 1. Changes in Percutaneous Transluminal Coronary Angioplasty Practice and Outcome
Variable
Study (ref no.)
NHLBI-I (20) NHLBI-II (21) MAPS (22) BARI (23) MCD (22)
Years of entry 1977–1981 1985–1986 1991 1989–1992 1990–1994
No. of patients 1,155 1,802 200 915 3,787
New device use No No Yes No Yes
Baseline factors
Mean age (yr) 54 58 62 62 61
Women 25% 26% 28% 27% 32%
Unstable angina 37% 49% 52% 63% 63%
Multivessel disease 25% 53% 100% 100% 51%
Angiographic success 68% 91% 92% 88% 89%
Clinical success 61% 78% 90% 80% 87%
Complications
Death 1.2% 1.0% 1.0% 1.1% 0.9%
Q wave MI 4.9% 4.3% 1.5% 2.1% 1.0%
Emer. CABG 5.8% 3.4% 1.0% 6.3% 1.4%
BARI 5 Bypass Angioplasty Revascularization Investigation; Emer. CABG 5 emergency coronary bypass graft
surgery; MAPS 5 Multivessel Angioplasty Prognosis Study; MCD 5 multicenter database; MI 5 myocardial infarction;
NHLBI 5 National Heart, Lung, and Blood Institute; ref 5 reference.
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Complications can be divided into three mechanistic cate-
gories:
1. Coronary vascular injury. Although the angioplasty
process produces a controlled vascular injury, on occasion, the
treated site’s response to the intervention fails to achieve a
stable patent result. Catheter-induced coronary vascular injury
can also occur at sites remote from the target site, and
embolization of thrombotic or atherosclerotic material can
originate either from the catheters or from the coronary
vessels.
2. Other vascular events. Other vascular events are caused
either by injury to a noncardiac vessel by catheter insertion and
manipulation or by embolization of thrombotic or atheroscle-
rotic material.
3. Systemic nonvascular events. Systemic nonvascular
events are adverse events caused by the procedure but not due
to vascular injury. They include all the systemic hazards of
cardiovascular X-ray angiographic procedures, including con-
trast agent-induced adverse events. The two most prominent
events are contrast agent-induced nephropathy and acute
pulmonary vascular congestion.
Complications may be divided into six basic outcome cate-
gories:
1. Death: related to the procedure, regardless of mechanism
2. MI: related to the procedure, regardless of mechanism
3. Emergency CABG: either as a result of procedure failure or
a procedure complication
4. Vascular access site complications
5. Stroke
6. Contrast agent nephropathy
Because adverse events are hard end point outcome events,
they are easily recognized and captured for statistical summary
purposes. The ACC, through its database program, has devel-
oped a comprehensive data dictionary of recognized adverse
events with rigorous definitions (25). It may be possible to
determine conclusively whether death or a complication was
caused by a procedure. Nonetheless, for the purposes of
monitoring performance, a rate of complications or deaths
substantially above that expected, after adjustment for patient
risk factors, is cause for concern about poor quality.
VII. Patient, Lesion and Institutional
Variables Influencing Success and
Complication Rates
A number of changing factors have improved the overall
success and complication rates of coronary interventional
procedures. These include increased operator experience, im-
provements in conventional instrumentation (balloon cathe-
ters, guide catheters, guide wires), newer interventional de-
vices (stents, atherectomy devices) and newer adjunctive
pharmacologic therapy. Concurrently, these improvements
have also led to the extension of interventional treatment to
higher risk patients with more complex coronary anatomy and
comorbid disease. These factors together have influenced
overall acute and long-term outcome associated with coronary
interventional procedures.
A. Measures/Definitions of Success
1. Anatomic success. This definition focuses exclusively on
the enlargement of the lumen at the target site. Although there
has been disagreement over the definition of a qualifying
increase in minimal lumen diameter, the current consensus
definition is the achievement of a minimal stenosis diameter
reduction to ,50% (assessed by angiography) (7). There
frequently is a disparity between the visual assessment of
lumen diameter and computer-aided quantitative measure-
ment (26,27). This disparity potentially makes the determina-
tion of this important measure problematic, particularly when
success rates are self-reported.
2. Procedural success. Procedural success may be defined as
the achievement of anatomic success without major complica-
tion (death, MI, emergent CABG) (7,20). Although the occur-
rence of emergent CABG and death are easily identified end
points, the definition of periprocedural MI has been more
problematic. Some definitions require the development of Q
waves in addition to a threshold value for creatine kinase (CK)
elevation. However, more recent reports have identified non-Q
wave MIs with CK elevations three to five times the upper limit
of normal as having clinical significance (28).
3. Short-term clinical success. Short-term clinical success
requires, in addition, to procedural success, the successful
relief of signs or symptoms, or both, of myocardial ischemia
after the patient recovers from the procedure.
4. Long-term clinical success. Long-term clinical success
requires that the short-term clinical success remains durable
and that the patient has persistent relief of signs and symptoms
of myocardial ischemia for .6 months after the procedure.
Restenosis is the principal cause of lack of long-term clinical
success when a short-term clinical success is achieved. The
frequency of clinically important restenosis may be judged by
the frequency with which subsequent revascularization proce-
dures are performed after the index procedure.
B. Patient and Lesion Characteristics Related to
Procedural Success and Complication Rates
Angioplasty procedural success and complication rates are
heavily influenced by a variety of patient and target lesion
characteristics. These variables must be taken into consider-
ation through risk adjustment when assessing adverse event
rates. In addition, they must also be weighed in determining
procedure appropriateness.
1. Patient clinical characteristics. Several studies have
reported specific clinical factors to be associated with an
increased risk of an adverse outcome after balloon angioplasty.
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These include advanced age, female gender, unstable angina,
congestive heart failure and multivessel coronary disease (29–
32). The Bypass Angioplasty Revascularization Investigation
(BARI) trial (23) found diabetes mellitus in patients with
multivessel disease to be associated with increased periproce-
dural ischemic complications and increased mortality over 5
years compared with patients without diabetes or patients with
diabetes undergoing CABG. Patients with impaired renal
function, particularly diabetic patients, are at increased risk for
contrast agent nephropathy (33).
2. Target lesion anatomic factors. Numerous studies have
identified particular lesion morphologic characteristics and the
absolute stenosis severity as predictors of immediate outcome
during coronary angioplasty (29,30). Features such as lesion
eccentricity, angulation, length and presence of thrombus have
been independently associated with abrupt vessel closure and
major ischemic complications. On the basis of these observa-
tions, the ACC/AHA task force (5) proposed a classification
scheme based on lesion morphology to estimate the likelihood
of procedural success and complications. This scheme was
subsequently modified by other investigators (29) but has
served as a useful guide for assessing the risk of an adverse
outcome associated with a particular lesion. However, more
recent experience suggests that improved devices and tech-
niques have improved success rates in more complex lesions
(34,35). As a result, lesion morphology may be a less important
predictor of complications currently than it has been in the
past.
C. Strategies for Risk Stratification
Several large retrospective studies of patients undergoing
coronary angioplasty have identified both clinical and angio-
graphic characteristics that correlate with procedural success
as well as in hospital morbidity and mortality. The independent
predictors of procedural success and major complications
during coronary angioplasty noted in these studies are shown
in Tables 2 and 3. These observations have been used to
develop multivariate logistic regression models that can stratify
patients into risk groups before the procedure (20,29–32).
D. Impact of the Facility on Procedural Success
1. Physical facility requirements. The physical facility in
which interventional procedures are performed has an impor-
tant impact on procedural success. The facility must provide
optimal radiologic, monitoring and patient support equipment
to enable operators to perform at the best of their ability.
Radiologic imaging equipment must provide optimal live video
and film image quality to facilitate accurate catheter and
device placement and to enable proper assessment of proce-
dure results (8). Physiologic monitoring equipment must func-
tion to provide continuous, accurate information about the
patient’s condition. Requisite support equipment must be
available and in good operating order to respond to whatever
emergency situations may arise.
2. Overall institutional system requirements. The interven-
tional laboratory does not function in a vacuum. An extensive
support system of specifically trained laboratory personnel and
immediately available cardiothoracic surgical, respiratory and
anesthesia services is essential to respond to emergency situa-
tions to minimize their detrimental outcomes. In addition, the
institution through its systems of credentialling, governance,
data gathering and quality assessment monitoring provides
important quality control over the entire interventional pro-
gram.
VIII. Non-Balloon Devices for
Coronary Interventions
There are an increasing number of devices that can be used
to enhance the results of percutaneous coronary revasculariza-
tion. Some of these are alternative stand-alone devices, but the
majority require balloon dilation either before, during or after
Table 2. Multivariate Predictors of Procedural Success* in
3,706 Patients
Variable OR (95% CI)
p
Value
Modified ACC/AHA lesion score B2 or C 0.65 (0.52, 0.80) 0.000
Modified ACC/AHA lesion score C 0.67 (0.52, 0.86) 0.002
Previous restenosis 1.37 (1.01, 1.87) 0.045
Age . 80 yr 0.61 (0.37, 1.00) 0.051
*Data from Ellis et al. (29). ACC/AHA 5 American College of Cardiology/
American Heart Association; CI 5 confidence interval; OR 5 odds ratio.
Table 3. Multivariate Predictors of Complications* During
Coronary Angioplasty
Study (ref no.) and Variable OR (95% CI)
p
Value
Kimmel et al. (32), 10,622 pts
Age 1.01 (1.00, 1.03) , 0.05
Acute MI within 24 h 2.20 (1.25, 3.86) , 0.01
Geographic region
Northeast 1.00
South 1.51 (1.03, 2.21) , 0.05
West 4.64 (1.99, 10.8) , 0.001
LMCA attempted 5.91 (2.36, 14.8) , 0.001
Multivessel disease 1.59 (1.03, 2.45) , 0.05
Previous CABG 0.50 (0.25, 0.98) , 0.05
Shock 4.11 (2.13, 7.92) , 0.001
Unstable angina 1.54 (1.17, 2.03) , 0.001
Type C lesion 1.67 (1.13, 2.46) , 0.001
Ellis et al. (29), 4,860 pts
LVEF , 0.40% 2.63 (1.70, 4.06) 0.000
Modified ACC/AHA type C lesion 2.50 (1.55, 4.02) 0.000
AMI 4.31 (1.60, 11.64) 0.005
Shock 7.47 (1.37, 40.74) 0.020
Previous CABG 0.53 (0.28, 1.02) 0.059
Prior restenosis 0.53 (0.27, 1.03) 0.061
*Death, myocardial infarction, emergency coronary artery bypass graft
surgery. LMCA 5 left main coronary artery; LVEF 5 left ventricular ejection
fraction; pts 5 patients; other abbreviations as in Tables 1 and 2.
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their use to fully optimize the final result. The specific utility of
these new devices is constantly changing as operator experi-
ence and technological improvements occur and as a result of
refinements in an understanding of their indications based on
results of single and multicenter registries and randomized
trials.
A. Classification of Non-Balloon Devices
One conceptual framework for categorizing these newer
devices divides them into three categories (Table 4): 1) those
that can be used to extend the application of percutaneous
procedures to lesion or patient groups that are usually consid-
ered to be treated suboptimally by conventional dilation
technology; 2) those that are used to treat complications of
percutaneous revascularization; and 3) those that can be used
to prevent restenosis. New devices continue to be added to
each of these categories. Some devices fall into more than one
group, such as stents, which are commonly used for all three
indications.
1. Devices that extend application of percutaneous revas-
cularization. This is the largest category of devices and in-
cludes stents, rotational atherectomy, DCA, transluminal ex-
traction atherectomy (TEC) and laser atherectomy. The use of
these devices is predicated on the concept that specific angio-
graphic lesion characteristics are associated with suboptimal
results with conventional balloon angioplasty. This concept
forms the basis for the modified ACC/AHA classification (5).
Some of the lesion characteristics that are associated with
increased complications include old vein graft lesions, ostial
lesions, diffuse disease and total chronic occlusion (30,36–39).
Because the use of these non-balloon devices is often elective,
not every operator needs to be trained in the performance of
all devices in this category. Non-balloon devices have been
demonstrated to improve the acute angiographic and clinical
results in these situations (40–46); however, even with adverse
lesion morphology, conventional dilation may still yield an
excellent result and may continue to improve with develop-
ment of new catheter technology.
2. Devices used to treat complications of interventions. In
contrast to the devices that are used electively to extend the
application of percutaneous intervention and do not need to be
learned by all interventional cardiologists, all interventionalists
need to be able to react to salvage a failed angioplasty
procedure. The most common complication treated is coro-
nary dissection and subsequent acute or threatened closure
(30,47,48). Stents are most commonly used to treat these
complications, although DCA may also play a role. Other less
frequent complications include perforation or atherothrombo-
embolism (49). Thus, competence in stent placement is a
required skill for all interventional cardiologists.
3. Devices used to prevent restenosis. Coronary stents have
been shown to reduce restenosis in selected patients with
primary stenoses in large native coronary arteries (50,51).
Recent studies have documented that DCA also reduces
restenosis (52). Although both devices can reduce restenosis in
selected patients, it has yet to be shown that they are effective
in less favorable anatomic situations. Given the improvement
in outcome with stents and DCA in selected patients, it can be
argued that all interventional cardiologists should have access
to them. Not all interventionalists need to be able to perform
DCA themselves because its use is generally elective. However,
each facility should have interventionalists trained in DCA.
B. Competence in Non-Balloon Devices
1. Specific cognitive and technical skills required. Each
operator utilizing the newer interventional devices must be
experienced with conventional balloon PTCA. Given the dif-
ferent technical skills and clinical application of each device,
the specific cognitive and technical skills for the newer devices
vary substantially. Some of the non-balloon procedures, such
as DCA and rotational atherectomy, are complex and require
additional skills because the procedure is significantly different
than conventional PTCA. DCA utilizes large devices and
requires more technical skill and experience in selective cutting
and knowledge to determine when optimal tissue removal has
been achieved. Rotational atherectomy requires technical skill
to prevent complications, such as dissection, no reflow and
hemodynamic compromise, which are usually not seen with
conventional PTCA. Other devices also have their own tech-
nical considerations, such as saline flushing with laser and
minimizing of distal embolization with TEC. Stents are tech-
nically easier to use but still have unique potential problems,
such as inadequate expansion of the stent, side branch occlu-
sion by the stent and device movement. Current stent technol-
ogy available in other countries makes these problems consid-
erably less formidable. Finally, the adjunctive medications
required may vary among devices, including, among others,
newer antiplatelet agents, which may not be routinely required
for conventional PTCA.
2. The learning curve and obtaining and maintaining
competence. The learning curve includes both cognitive and
technical aspects. Appropriate patient and lesion selection is
essential to optimize outcome. As previously mentioned, the
initial requirement is demonstrated competence and experi-
ence with conventional balloon PTCA. Participation in educa-
tional programs devoted to the specific device is also necessary.
Table 4. Non-Balloon Devices and Indications for Use
Device or Procedure* Planned Procedure† Unplanned Procedure‡
Stents Stents Stents
DCA DCA DCA
Rotablator
TEC
Laser
*Used to extend percutaneous revascularization to a wider number of
patients and lesions. †Prevention of restenosis. ‡Treatment of complications of
interventional procedures. DCA 5 directional coronary atherectomy; TEC 5
transluminal extraction atherectomy.
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These programs should specifically address technical details of
device performance, patient selection, risks/complication man-
agement and adjunctive treatment. Finally, performing the
new procedure with the assistance of an experienced operator/
mentor highly skilled in the procedure is essential.
3. Maintenance of competence. After initial training, main-
tenance of competence is critically important. The number of
cases required for maintenance of competence depends on the
operator’s overall experience as well as the complexity of the
procedure. More complex procedures using non-balloon de-
vices require a greater level of continued experience. Every
attempt should be made to concentrate the experience of these
more complex and less frequently performed procedures in the
hands of a small number of higher volume interventionalists.
Maintenance of competence should require that patient out-
come be determined longitudinally for each procedure by the
institution’s quality assessment program, which includes per-
formance evaluation and feedback to the operator.
C. Role of and Indications for New Devices
Compared With Other Technology
The role of non-balloon devices continues to evolve as
experience grows and technology improves (Table 5). These
devices are often more demanding to use than conventional
balloon technology and are often used in patients with more
complex and riskier clinical circumstances. The goals in using
these devices must be kept in mind because they are most often
used as adjuncts to conventional balloon PTCA. The ability to
use stents to treat acute or threatened closure is an essential
skill for all interventional cardiologists. Other procedures, such
as DCA and rotational atherectomy, can be used as part of a
preplanned strategy. Thus, not all interventionalists need to be
trained to use these devices. In such circumstances, if a
physician is not trained with one of these types of devices, the
patient can be transferred, an alternative approach selected, or
a colleague with greater experience can be called on to assist.
This mentoring approach is particularly valuable with non-
balloon devices, where rapidly changing technology and highly
selected indications make it impossible for all interventional-
ists to be adequately skilled to perform an optimal procedure.
IX. Components of Operator Competence
and Skill in Coronary
Interventional Procedures
A. Cognitive Knowledge Base
The cognitive knowledge needed to perform coronary
intervention has been addressed previously by expert panels
and independent authors (4–7,9–11,53). This core knowledge
along with certain technical skills, will be evaluated in the
future by the Added Qualification Examination Interventional
Cardiology of the ABIM. It is the consensus of the authors of
this and earlier reports that a competent operator must have a
knowledge of the anatomy, physiology and pathophysiology of
the heart and of the coronary and systemic circulation. A
particular requirement is an in-depth understanding of the
interactions of these entities with left ventricular dysfunction
and acute myocardial ischemia and infarction.
The pivotal role of blood coagulation and vascular biology
in coronary artery disease makes it essential that operators
have a thorough understanding of those elements of coagula-
tion, atherosclerosis and vascular repair that relate to the
pathogenesis and treatment of stable and unstable ischemic
syndromes. Of particular importance is an understanding of
the physiology, pharmacology and potential value of antiplate-
let, antithrombin and thrombolytic agents because they are
used frequently in coronary interventional procedures. Specific
knowledge of the treatment of bleeding complications related
to these agents is necessary. Knowledge of the results of
observational and randomized trials that have evaluated these
agents is essential to guide their application.
Competent operators must have knowledge of the indica-
tions for percutaneous coronary intervention, medical therapy
and operation in the broad spectrum of patients with coronary
disease. This knowledge should be based on an in-depth
understanding of published clinical trials (both randomized
and observational of treatment strategies in coronary artery
disease, including comparisons of coronary angioplasty with
surgical and medical therapy; comparisons of conventional
coronary angioplasty with DCA stents and other devices;
comparisons of direct coronary angioplasty with thrombolytic
therapy as the primary therapy in acute MI; and the role of
coronary angioplasty as a treatment for recurrent ischemia and
other clinical problems after MI. This knowledge, supported by
personal clinical experience, enables the rational selection of
patients to be treated with percutaneous intervention. It also
guides the selection of the optimal procedure strategy based on
specific anatomic and clinical features, with the aim of achiev-
ing myocardial revascularization that is safe, effective, as
durable as possible and cost-effective.
Table 5. Role and Performance of Specific Non-Balloon Devices
Device or
Procedure Indication* For Use By Alternative to Use
Stents 1, 2, 3 Required for all
interventional
cardiologists
Perfusion balloon, CABG
Rotablator 1 Selected experienced
interventionalists
Patient referral, mentor/
proctor, CABG,
alternative Rx
DCA 1, 2, 3 Selected experienced
interventionalists
Patient referral, stent
placement, mentor/
proctor, CABG
TEC 1 Selected experienced
interventionalists
Patient referral, mentor/
proctor, alternative Rx
Laser 1 Selected experienced
interventionalists
Patient referral, mentor/
proctor, CABG,
alternative Rx
*1 5 extend application of treatment to a wider number of lesions; 2 5
treatment of complications; 3 5 prevention of restenosis. Rx 5 therapy; other
abbreviations as in Tables 1 and 3.
732 HIRSHFELD ET AL. JACC Vol. 31, No. 3
CORONARY INTERVENTIONAL PROCEDURES March 1, 1998:722–43
A knowledge of contraindications to percutaneous inter-
vention is essential. Among those patients in whom coronary
intervention is, in general, contraindicated are patients with
left main coronary disease who are candidates for coronary
bypass and asymptomatic patients with critical stenoses in
relatively unimportant coronary arteries or with noncritical
stenoses.
To perform coronary intervention competently, physicians
must have a thorough knowledge of the specialized equipment
used, including 1) the theoretical and practical aspects of X-ray
imaging, radiation physics and safety (use of image intensifiers
and other equipment to generate digital images, quality control
of images, image storing, consequences of exposure of patients
and personnel to ionizing radiation and methods of reducing
their exposure); 2) a working knowledge of catheterization
laboratory equipment (physiologic data recorders, pressure
transducers, blood gas analyzers, defibrillators); and 3) a
thorough knowledge of supplies and devices used in coronary
intervention, including catheters, guide wires, balloon cathe-
ters, stents, atherectomy devices, ultrasound catheters, in-
traaortic balloon pumps, puncture site sealing devices and
contrast agents.
Operators must have an in-depth knowledge of procedural
complications, including their prevention, prompt recognition
and treatment. In addition to coronary dissection and abrupt
closure, knowledge of a number of “new” complications and
insights is essential. These include coronary perforation re-
lated to ablative devices and stents, slow and no reflow due to
microembolization or macroembolization or microcirculation
alterations, the importance of prevention of non-Q wave MI,
the hemorrhagic complications of newer and more potent
antithrombotic agents, the prevention and management of
peripheral vascular complications (expanding hematoma,
pseudoaneurysm, arteriovenous fistula), the recognition and
treatment of embolic and hemorrhagic stroke and the preven-
tion of contrast agent-induced nephropathy.
For informed consent, a basic patient right, to be exercised
and documented, it is essential that interventional operators
have a clear understanding and ability to communicate the risk,
potential benefits, treatment alternatives and results of percu-
taneous intervention to the patient, his or her family, to the
medical record and to others involved in the care of the
patient.
B. Technical Skills
As in any surgical procedure, percutaneous coronary artery
revascularization requires that the operator possess certain
requisite technical skills. Many of the skills are closely related
to those needed to perform diagnostic cardiac catheterization
and coronary angiography. These include a degree of manual
dexterity and the ability to maintain sterile surgical technique
and to obtain percutaneous arterial and venous access.
Most of the other required technical skills are unique to
coronary interventional procedures and can only be acquired
by training in actual procedures under the direction of an
experienced interventionalist. These include the manipulation
and operation of guide catheters, coronary angioplasty guide
wires, coronary angioplasty balloon catheters, atherectomy
devices, stents, intracoronary ultrasound catheters and other
intracoronary devices. Because there is a substantial variation
from procedure to procedure in the nature of device manipu-
lation maneuvers, the interventionalist must be exposed to a
comprehensive mix of simple and complex cases.
Operators must have the technical skill to perform proce-
dures necessary to diagnose and treat complications of coro-
nary intervention that are frequently life threatening if not
treated in a precise and timely fashion. These include place-
ment of coronary perfusion catheters, intraaortic balloon
pumps, cannulation for percutaneous cardiopulmonary bypass
and emergent placement of stents to stabilize an angioplasty
site that exhibits abrupt or threatened closure.
Because adverse events occur rarely, operator competence
requires specific training and ongoing experience in managing
them so as to be prepared to react optimally when they occur.
In the training phase and subsequently, it is desirable to use
supplemental case studies of the technical management of
infrequent but serious complications of these procedures.
X. Determinants of Appropriateness in
Coronary Interventional Procedures
Judgment of the overall quality of an interventional cardi-
ology program and individual physician-operators must also
consider procedure appropriateness. The ability to perform a
given procedure successfully without acute complications does
not necessarily mean that the procedure was appropriate.
The ultimate determinant of the appropriateness of a
cardiovascular therapy is whether it has the optimal beneficial
impact on long-term patient outcome. Because coronary inter-
vention is one of several potential treatment options available,
its appropriateness to a particular patient’s clinical situation is
determined by what it can achieve compared with alternative
treatment strategies, such as surgical revascularization and
medical therapy.
A number of elements contribute to determining the ap-
propriateness of a coronary interventional procedure. These
include
1. The likelihood of the procedure’s short-term success is
determined principally by anatomic characteristics of the tar-
get lesion or lesions. The determinants of likelihood of proce-
dural success are discussed in detail in Section VIIB. The
target lesion’s anatomic characteristics influence the technical
difficulty of executing the procedure and the likelihood that the
lesion will respond appropriately to the intervention. The
likelihood of success is also heavily influenced by the particular
physician-operator’s technical skill, cognitive knowledge and
selection of the particular interventional technique.
2. The likelihood and potential consequences of procedural
failure and complications determine the risk of the procedure.
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They are determined by the patient’s overall clinical condition,
the anatomy of the patient’s coronary artery disease and
ventricular function.
3. The likelihood that a successful procedure will achieve a
durable long-term result. The principal deficiency of coronary
interventional procedures is restenosis. The lesion attributes
that determine the likelihood of restenosis are well character-
ized. The appropriateness of interventional treatment for a
lesion that has an extremely high likelihood of recurrence is
questionable if alternative treatment strategies exist.
4. The relative efficacies of alternative treatment strategies. For
a particular patient it is important first to consider the relative
benefit of a revascularization treatment strategy as opposed to
a purely pharmacologic approach. A revascularization treat-
ment strategy is appropriate if it provides a clinically important
long-term benefit in terms of symptoms or survival superior to
that which can be achieved by pharmacologic therapy. If
revascularization is the optimal treatment strategy, it is then
important to consider the relative benefits of interventional
versus surgical approaches. These judgments are influenced by
the relative likelihoods of long-term success, complications and
the associated morbidities that accompany alternative proce-
dures.
Consequently, in a number of circumstances, short-term
outcome statistics may fail to disclose the inappropriateness of
coronary interventional procedures and, accordingly, do not
fully assess overall operator proficiency and clinical judgment.
For example,
1. An overly conservative or cautious physician might
restrict case selection to patients with a straightforward ana-
tomic situation. Such selection criteria will optimize short-term
procedural outcome statistics, suggesting that the physician is a
skilled, proficient operator. However, these conservative selec-
tion criteria may deny the potential benefits of interventional
therapy to other patients with more complex, challenging
clinical and anatomic situations who might benefit from it.
2. An aggressive physician may perform interventional
procedures in patients with relatively mild coronary disease
who would be expected to do well with pharmacologic therapy
alone. This strategy also yields excellent short-term outcome
statistics but subjects patients to marginally indicated proce-
dures.
3. A physician may select lesions with an extremely high
probability of restenosis for interventional treatment. Al-
though short-term outcome statistics may be excellent, a
frequency of high restenosis may cause long-term benefit to the
patients to be minimal or absent.
4. An aggressive physician may choose to perform interven-
tional procedures in complex, seriously ill patients with exten-
sive coronary disease, who either are candidates for surgical
revascularization or are poor candidates for any revasculariza-
tion procedure. This case selection strategy jeopardizes pa-
tients both by subjecting them to a substantial procedural risk
and by failing to offer surgical revascularization where appro-
priate.
XI. Data Relating Operator and Institutional
Experience and Activity to Outcome in
Coronary Interventional Procedures
A. Evidence Reviewed
Computerized literature searches of English language pub-
lications, review of recent abstract publications and solicitation
of manuscripts under review for publication from many physi-
cians and epidemiologists expert in the field were used to
compile the relevant available scientific evidence relating
operator and institutional activity level to outcomes (Table 6
and 7). In general, greater weight was given to recent, fully
peer-reviewed publications of high quality. No single work was
considered definitive. It was recognized that many analyses
were limited to some extent by an incapacity to fully adjust
expected outcomes for differences in patient characteristics, by
questionable generalizability and by changes and advances in
the field of interventional cardiology. From the standpoint of
statistical validity, it needs to be recognized that studies
attempting to correlate hospital or physician experience with a
relatively uncommon complication, such as death or un-
planned bypass surgery, need to study 200 to 400 hospitals or
physicians to have adequate power to detect the type of modest
relation that has been suggested by the largest studies of this
issue. For example, to have 90% power to detect a correlation
with r 5 0.17 at p 5 0.05, ;300 evaluatable units are required
(Solo Power Analysis 1.0, BMDP Statistical Software). Many
published studies are vastly underpowered. In the absence of
clear-cut data, a general consensus of the expert physician
panel was sought.
B. Relation of Institutional Volume to
Procedural Outcome
The preponderance of data suggest that, on average, hos-
pitals in which fewer coronary interventions are performed
have a greater incidence of procedure-related complications,
notably death and need for bypass surgery for failed interven-
tion, than do hospitals performing more procedures. Multiple
data sources support the existence of a curvilinear, perhaps
logarithmic, statistical relation between caseload and outcome
(Table 6). Ritchie et al. (54) were the first to report this
relation and analyzed administrative datasets from 24,883
interventions performed at 110 nonfederal California hospitals
during calendar year 1989. The patients were classified accord-
ing to whether they presented with the principal diagnosis of
acute MI. In both groups, a strong statistical relation (p ,
0.001) was found when the rates of bypass surgery or death, or
bypass surgery alone, between hospitals classified as low (#200
cases/year), intermediate (201 to 400 cases/year) or high
volume (.400 cases/year) were compared. For example, the
incidence of the combined end point of bypass surgery or death
for patients with an acute MI in the low, intermediate and high
volume hospitals was 12.4%, 10.0% and 8.3%, respectively. For
patients not presenting with an acute MI, these rate were 6.3%,
4.7% and 4.4%, respectively. However, there were no statisti-
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cally significant differences in the end point of in-hospital
mortality, although there was a weak trend for a similar
relation for patients presenting with an acute MI for the low,
intermediate and high volume hospitals (4.5%, 4.3%, and
3.6%, respectively).
In 1994, Jollis et al. (55) reported the results of their
analysis of national Medicare provider analysis and review
(MEDPAR) administrative data for all procedures in Medi-
care beneficiaries performed during calendar years 1987 to
1990 (217,836 patients treated at 1,194 hospitals). Using
logistic regression analyses to adjust for potential imbalances
in patient baseline characteristics, they found the number of
PTCA procedures performed at a hospital to be a highly
significant predictor of in-hospital mortality (p # 0.001). This
relation did not appear to be linear, with the data suggesting
an inflection point ,200 Medicare procedures/year (;600
total procedures). The likelihood of bypass surgery after
angioplasty was similarly related to hospital volume, al-
though the inflection point appeared to be perhaps at a
somewhat higher hospital volume. However, the absolute
magnitude of the differences between hospitals with varied
caseloads was relatively modest. For example, the in-
hospital mortality rate for hospitals with .200 procedures/
year performed in Medicare patients was ;2.5%, rising to
;3.3% for those hospitals with ;100 cases/year.
In a similar analysis using more recent data, Jollis et al. (55)
analyzed data from all Medicare billing claims during calendar
year 1992, obtaining data on treatment of 97,478 patients at
984 hospitals. After adjustment for age, gender, presentation
with acute MI and comorbidities, they found the likelihood of
bypass surgery or death to have a strong statistical associa-
tion (p , 0.001) with hospital caseload, as depicted in
Figure 1A. Their analysis suggested a nonlinear relation
between these complications and hospital volume, with an
inflection point between 200 and 300 Medicare cases (600
and 900 total cases).
Recently, data have been available from the New York
State experience (56) between 1991 and 1994 (62,670 patients
treated at 31 hospitals) (Fig. 1, B and C). The strength of this
analysis lies in the fact that the investigators were able to use
a more comprehensive database than the administrative data-
sets used in previous analyses and that the data were subject to
external audit. Risk-adjusted mortality rates were increased for
hospitals with ,400 cases/year. The risk-adjusted incidence of
Table 6. Published Data Relating Hospital Coronary Angioplasty Volume to Complication Rates
Study (ref no.) Data Source
No. of Pts/
Hospitals Studied Conclusion Comment
Hartz et al. (64) 1989–1991 Wisconsin Medicare 2,091/16 No relation between volume and outcome Very low number of cases
and hospitals examined
Ritchie et al. (54) 1989 California State (Adm) 24,883/110 Increased CABG (not death) , 200 cases/
yr; finding is valid for both acute MI
and non-acute MI pts
Jollis et al. (55) 1987–1990 MEDPAR (Adm) 217,836/1,194 Death and CABG inversely related to low
volume (risk increases with Medicare
pt volume* (, 100–200 total/yr for
death, , 200–300/yr for CABG)
Kimmel et al. (59) 1992–1993 SCA&I 19,594/48 Fewer major complications for labs with
. 400 cases/yr
Able to risk adjust more
completely than most
other analyses
GUSTO (IIb) Angioplasty
Substudy Group (19)
GUSTO IIb trial 565/59 No difference, 200–625 vs. . 625 cases/yr.
for acute MI pts
All operators . 50 cases/yr
Kato and Carter (57) 1991 HCFA (RAND Corp.) 113,576/862 Except for Medicare volume* , 50,
higher volume hospitals had higher
mortality rates
O’Neill et al. (65) PAMI II trial 1,100/34 No difference, , 500, 501–1,000, . 1,000
cases/yr for acute MI pts
Jollis et al. (3) 1992 Medicare (Adm) 97,498/984 Incremental decrease in death1bypass
surgery as hospital Medicare volume*
, 100, 100–200, $ 200/yr
Tiefenbrunn et al. (66) Second National Registry of
MI (U.S.)
4,939/? Increased acute MI mortality for hospital
, 25 acute MI cases/yr
Hannan et al. (56) 1991–1994 NY State 62,670/31 Death alone and same-stay CABG
increased with annual caseloads , 600
Risk adjusted
Zahn et al. (67) 1992–1995 German Hospital
Consortium
4,625/? For pts with acute MI; increased
mortality in hospitals with , 40 acute
MI PTCA/yr
No risk adjustment
*Medicare patients usually comprise 35% to 50% of total interventional caseload. Adm 5 administrative dataset; GUSTO 5 Global Use of Strategies to Open
Occluded Coronary Arteries in Acute Coronary Syndromes; HCFA 5 Health Care Financing Administration; labs 5 laboratories; MEDPAR 5 Medicare provider
analysis and review; PAMI 5 Primary Angioplasty in Myocardial Infarction; PTCA 5 percutaneous transluminal coronary angioplasty; SCA&I 5 Society for Cardiac
Angiography and Interventions; other abbreviations as in Tables 1 and 3.
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bypass surgery appeared to increase in hospitals with ,600
cases/year.
The only large-scale study not suggesting an inverse relation
between caseload and complications was that of Kato and
Carter (57) who analyzed 113,576 patients treated at 862
hospitals using the Health Care Financing Administration
(HCFA) data from 1991. Because a full report of this analysis
has not been published, it is difficult to critique. There is no
description of any risk adjustment attempt.
However, procedural volume is only one of many factors
contributing to the variability of measured outcomes
(56,58,59). Furthermore, there is no clear “cutoff ” above or
below which hospitals, or groups of hospitals in aggregate,
perform well or poorly. There are institutions with low volumes
that appear to achieve very acceptable results. For an individ-
ual institution, however, such an impression must be tempered
by the statistical imprecision of the estimate of risk.
C. Relation of Individual Operator Volume to
Procedural Outcome
Interpretation of data supporting the contention that there
is, on average, an inverse relation between an individual
operator’s annual caseload and likelihood of complications is
more difficult than for hospital volume and outcome.
The four largest studies to assess a potential relation
between individual operator caseload and procedural compli-
cations all find that such an inverse relation exists. In the
largest study, the analysis of 1992 Medicare patient outcomes
(97,478 Medicare patients) by Jollis et al. (55), the incidence of
unplanned bypass surgery after angioplasty rose significantly
with decreasing caseload and with no obvious inflection point
(Fig. 2A). For example, the likelihood of bypass surgery was
;2.5% in Medicare patients treated by a physician performing
100 procedures/year, 3.0% for a physician performing 50
procedures/year and as high as 3.7% for physicians performing
30 procedures/year. No consistent relation was found between
operator caseload and in-hospital death. The 1991 to 1994 New
York State experience (56) was somewhat similar, with a
significant increase in the risk of bypass surgery with lower
volume operators and only a trend in a similar direction for
in-hospital mortality (Fig. 2, B and C). For example, the
risk-adjusted rate of bypass surgery for patients treated by
physicians with caseloads in excess of 175 cases/year was 3.0%
and increased to 3.9% for patients treated by physicians with
.75 cases/year. A similar trend, but of lesser magnitude, was
noted for in-hospital mortality. For example, the risk-adjusted
likelihood of in-hospital death for patients treated by operators
with $175 cases/year was 0.8% and increased to 1.03% for
patients treated by operators with ,75 cases/year.
Table 7. Published Data Relating Physician Coronary Angioplasty Volume to Complication Rates
Study (ref no.) Data Source
No. of Pts/
Operators Studied Conclusion Comment
Hamad et al. (68) 1986–1987 single center 787/17 Lower success with complex lesions (B–C) for
operators with , 100 cases/yr (no
difference for simple lesions)
Shook et al. (69) 1991–1994 single center 2,350/38 Higher risk of emer. CABG with operators of
, 50 cases/yr (but no difference for
mortality)
Ellis et al. (60) 1993–1995 high volume
centers
12,941/38 Risk of death and death, MI or emer. CABG
inversely related to case load but not years
of experience; no volume “cutoff,” but risk
“accelerates” at cases , 100/yr
Able to risk adjust more completely
than most other analyses
Krone et al. (70) 1992 SCA&I database 7,747/122 No differences, , 50, 50–99, . 100 cases/yr
(. 100 more complex lesions)
Able to risk adjust more completely
than most other analyses
Bon Tempo et al. (71) 1992–1994 single center 3,127/45 Weak trend toward increased risk of abrupt
closure and late PTCA with higher volume
operators
No risk adjustment
O’Neill et al. (65) PAMI II trial 1,100/? No difference for , 75, . 75 cases/yr Selected interventionalists only
Jollis et al. (55) 1992 Medicare (Adm) 97,478/6,115 More death1CABG for annual Medicare
volume* , 50
McGrath et al. (61) 1990–1993 Northern
New England Registry
12,033/31 Success and emer CABG, but not death,
related to volume tercile (23–85, 89–143,
153–450)
Hannan et al. (56) 1991–1994 NY State 62,670/? Death alone and same-stay CABG increase
with annual caseload , 75; an operator–
hospital caseload interaction affecting
outcome also observed
Risk adjusted
Klein et al. (72) 1992–1995 single center 1,389/9 Despite performing only an average of 51
PTCA/yr, results (death 5 0.1%, CABG 5
0.9%) were acceptable when compared
with contemporary registry data
*Medicare patients usually comprise 35% to 50% of total interventional caseload. Abbreviations as in Tables 1, 3 and 6.
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In the two other relatively large studies, Ellis et al. (60),
using data from five high volume institutions and 12,985
patients treated, and McGrath et al. (61), from the Northern
New England Cardiovascular Disease Study Group, evaluating
12,899 patients from five centers, found an inverse relation
between caseload and death and the combined end point
(death, infarction or bypass surgery) and bypass surgery but
not MI or death, respectively. Single-center experiences or
those derived from randomized trials with selected operator
participation have yielded more disparate results. Conse-
quently, it appears highly likely that there is a statistical
relation between individual operator procedural volume and
outcome, such that lower volume operators tend to achieve less
satisfactory results than higher volume operators. It is uncer-
tain whether this relation is a result of the “practice makes
perfect” principle or the fact that patients are more frequently
referred to high quality operators. However, this relation is not
universal. There are operators with an annual caseload that is
less than the previously defined ACC requirement of at least
75 cases/year for maintenance of competency who appear to
achieve acceptable results.
The relation between individual operator volume and out-
come is confounded by a possible an interaction between
physician and hospital volume, such that results of lower
volume operators in high volume institutions are generally
more favorable than those achieved by low volume operators
in low volume institutions. For example, New York State data
suggest that low volume operators (,75 cases/year) who
perform procedures in laboratories with .600 to 1000 cases/
year have superior outcomes to low volume operators who
perform procedures in lower volume laboratories. This rela-
tion also appears to exist for higher volume individual opera-
tors (56).
As with hospital volume and outcome, data relating physi-
cian volume to measures of quality in the current era are still
extremely limited. Thus, the impact of recently introduced
technologies (i.e., stents and platelet glycoprotein IIb/IIIa
inhibitors) on overall outcome, benchmark adverse event
rates and the previously demonstrated relation between
activity level and outcome has not yet been rigorously
assessed (62).
Furthermore, at present, little or no data exist linking
operator volume to case selection, periprocedural MI, long-
term clinical outcome or measures of cost-effectiveness, each
of which measures a component of outcome quality. Conse-
quently, there are important limitations to the simplistic
interpretation of raw complication rate statistics as a measure
of competence and quality.
Figure 1. Relation of hospital caseload to procedural
outcome in two recent major studies for A, death, bypass
surgery and death or bypass surgery combined from the
1992 Medicare database (on average, 35% to 50% of all
interventions are performed in all Medicare patients)
(55); B, risk-adjusted mortality rates (with 95% confi-
dence intervals) for the 1994 New York State experience
(56); and C, risk-adjusted risk of bypass surgery (with
95% confidence intervals) for the 1994 New York State
experience. Reprinted, with permission, from Hannan et
al. (56).
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XII. Conclusions and Recommendations
A. General Issues Related to Quality Assessment
In formulating conclusions and recommendations it is im-
portant to emphasize that the ultimate goal of such standard
setting is to facilitate the attainment of optimal patient out-
come. Institutional and programmatic quality is ultimately
determined by its success at achieving that goal.
Optimal outcome occurs when an operator selects clinically
appropriate patients for interventional procedures and per-
forms these procedures at a requisite level of proficiency. The
valid comprehensive assessment of patient outcome requires
more than merely compiling acute procedural success and
complication rates. True outcome must be assessed using
long-term measures of a patient’s cardiovascular health.
The information presented in the present document dem-
onstrates the difficulty in assessing operator proficiency and
institutional programmatic quality and the complexity of de-
veloping standards for maintenance of operator proficiency. At
the present time, measurement instruments for assessing over-
all cardiovascular health and the impact of an interventional
procedure on it are not well developed. Consequently, most
attempts to assess quality have been based on short-term
procedural success and complication rates. As discussed, this
approach, although an oversimplification, is the best approach
currently available.
B. General Observations
The current interventional cardiology information base
permits a number of broad general conclusions. Some are
based on statistical data published in peer-reviewed literature.
Others are, by necessity, based on reasoned judgments drawing
on what is known about the task of performing coronary
interventional procedures.
1. Coronary interventional procedures are complex and tech-
nically demanding to perform. Optimal performance of these
procedures requires an extensive cognitive knowledge base and
substantial technical skill. A particular procedure’s technical
difficulty and the optimal technique required to perform it
vary considerably from one case to another. The field is
evolving rapidly, with frequent introductions of new tech-
niques and instruments. Consequently, to be proficient, a
practitioner must perform procedures often enough to
maintain existing skills and to acquire new ones as the field
changes.
2. Complications of coronary interventional procedures, which
may be life threatening, sometimes occur unpredictably. A serious
complication can occur in a procedure that appeared initially
to be straightforward. Optimal patient outcome, once a com-
plication occurs, depends on proper recognition and manage-
ment. Optimal treatment of complications is a complex task
Figure 2. Relation of physician caseload to proce-
dural outcome in two recent major studies for A,
death or bypass surgery and death or bypass surgery
combined from the 1992 Medicare database (on av-
erage, 35% to 50% of all interventions are performed
in all Medicare patients) (55); B, risk-adjusted mor-
tality rates (with 95% confidence intervals) for the
1994 New York State experience (56); and C, risk-
adjusted risk of bypass surgery (with 95% confidence
intervals) for the 1994 New York State experience.
Reprinted, with permission, from Hannan et al. (56).
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that requires that the operator possess substantial experience,
knowledge and technical skill.
3. The most recently compiled comprehensive statistical data
set (New York State 1991 to 1994 [56]) found overall death and
emergency CABG rates for all types of coronary interventional
procedures in all circumstances to be 0.9% and 3.0%, respec-
tively. Risk-adjustment algorithms permit identification of high
and low risk subsets. There is ample reason to believe that
complication rates have decreased since those data were
collected (62). Consequently, these rates represent an absolute
upper limit for benchmark complication rates to be expected in
a clinically stable population.
4. There are consistent statistical associations between activity
levels and short-term complication rates (emergency CABG and
mortality) (3,55,56,58–60). These associations exist both for
institutions and for individual operators. The relations be-
tween activity levels and complication rates are curvilinear,
with rates decreasing as institutional activity increases to 600
procedures/year and operator activity increases to 175 proce-
dures/year (3,56). As a group, operators with activity levels
,75 procedures/year have both death and emergency CABG
rates that are statistically significantly greater than the rates for
operators with annual procedure volumes .75. Institutional
activity rates .600 procedures/year and operator activity rates
.175 procedures/year are not associated with a further de-
crease in complication rates. Although these relations do not
identify a clear-cut “competence threshold,” it is clear that on
average, operators and institutions with activity levels below
the above-cited values achieve poorer outcomes. Furthermore,
because most geographic areas have both a large number of
operators performing PTCA and a large number of PTCA
programs, there is little justification in terms of community
need for low volume operators and programs.
5. It is likely that there is an interaction between the institu-
tional program and the operator activity level in determining
complication rates. The highest complication rates occur for
low volume operators who perform procedures at low volume
institutions, whereas lower complication rates occur for low
volume operators who work at high volume institutions (3,56).
Thus, the institution, as the programmatic platform from which
individual operators perform procedures, has an important
impact on overall procedural effectiveness and safety.
6. The differences in the absolute magnitude of risk-
adjusted complication rates between low and high volume
institutions and operators are small. In the New York State
dataset (56), operators performing ,75 procedures/year had
mean mortality and CABG rates of 1.0% and 3.9%, respec-
tively, whereas higher volume operators had mean mortality
and CABG rates of 0.9% and 3.1%, respectively. The statistical
significance of these relations could be detected only with large
sample sizes, which indicates that not all low volume operators
and institutions are low volume nor are all high volume
institutions and operators necessarily of the highest quality.
The activity level effect appears to be stronger for emergency
CABG than for mortality, most likely because the three- to
fourfold greater frequency of CABG permits more precise rate
estimates.
7. The low expected complication rate for coronary interven-
tional procedures presents a major statistical power problem when
attempting to estimate the true complication rate of the low
volume operator with statistically meaningful precision. For
example, an operator must perform 100 complication-free
procedures to reasonably show that his or her true complica-
tion rate is ,3.6% (the upper limit of the 95% confidence
interval). The statistical power problem is further compounded
in that complication rates must be risk-adjusted to be inter-
pretable. As a result, the confidence intervals for estimates of
low volume operator complication rates will, in general, be too
large to permit accurate determination of an individual oper-
ator’s true performance relative to benchmark standards.
8. Unadjusted complication rates, although of some value for
assessing outcome, are incomplete assessments of overall operator
proficiency because they do not take into account patient char-
acteristics that influence risk. Furthermore, they do not assess
the appropriateness with which an operator selects cases.
Nonetheless, they do constitute a measurable parameter that is
linked to overall quality assessment.
9. Programmatic quality and individual operator proficiency
must be judged by rigorous quality assessment monitoring accord-
ing to standardized protocols using data that are not self-reported.
Because of statistical power issues, and to track trends over
time, outcome reporting from such a monitoring process must
be cumulative as well as limited to defined time periods.
10. Because there is a clear linkage between operator activity
level and outcome, there is a natural and appropriate focus on
operator activity levels that requires a rigorous standard for
measuring operator activity. One important ambiguity in assess-
ing operator activity occurs when more than one physician
participates in a procedure. Whether all physicians who par-
ticipate in a procedure may claim credit for having performed
the procedure has not been defined. The term “primary
operator” has been used frequently but has not been defined
precisely (see Appendix 1 for a definition of primary operator
developed by the Writing Group).
11. There are potential pitfalls in the use of complication rates
to judge operator proficiency. Such monitoring may affect an
operator’s case selection and judgment in a way that might
have an adverse impact on overall patient care. For example,
the pressure of complication rate monitoring might lead an
operator to withhold PTCA inappropriately from a challenging
patient who might benefit from the procedure. Similarly,
concern over his or her emergency CABG rate might cause an
operator to “ride out” an ischemic complication of a PTCA
procedure rather than refer a patient for emergency CABG.
C. Benchmark Complication Rates for
Quality Standards
The best subgroups of operators and institutions in the New
York State database (56) achieved a mortality rate of 0.9% and
an emergency CABG rate of 3%. With appropriate qualifica-
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tions, these rates can serve as benchmark rates against which to
judge operators and programs.
It should be emphasized that these data are derived from all
PTCA procedures, including those performed for acute MI
and cardiogenic shock. Thus, they overstate the risk of com-
plications in clinically stable patients undergoing elective
PTCA and understate the risk for high risk patients.
In principle, risk adjustment should be considered when
applying these rates as benchmarks. Application of risk adjust-
ment techniques to new data sets has had limited validation to
date. Consequently although risk adjustment is clearly impor-
tant, it should be applied carefully when making judgments
about individual operators and programmatic performance.
Furthermore the New York State data were gathered
before stents and platelet glycoprotein IIb/IIIa inhibitors were
in widespread use. It is likely that the availability of these
treatments has reduced the expected frequency of death and
emergency CABG. Consequently, these data may not accu-
rately reflect current practice, and the true current benchmark
complication rates may be lower. This emphasizes the need for
ongoing data gathering to determine the current benchmark
complication rates. The standard for benchmark complication
rates should be subject to future revision in response to the
emergence of newer data.
D. Guidelines for Institutions That Offer Coronary
Intervention Services
The institution, as the platform from which coronary inter-
ventional procedures are performed by individual physicians,
provides an important infrastructure that is essential to proce-
dural success. This infrastructure consists of both physical
(equipment) and intellectual (human) resources. Failure to
provide a high quality infrastructure will degrade the quality of
the services performed. In addition, the institution, as the basis
of governance of the health care system, is fundamentally
responsible for its program quality.
Institutions offering coronary interventional procedure ser-
vices should meet the following standards:
1. Quality assessment monitoring. It is essential that an
institution that offers a complex and potentially hazardous
procedure have a rigorous privilege-granting and quality as-
sessment monitoring system in place to determine the quality
and efficacy of its overall program and its individual physician
operators. Features of this program should include 1) estab-
lished criteria for privilege granting and privilege renewal; 2)
prospective recording of patient characteristic data to permit
appropriate risk stratification (the data elements of the ACC
PTCA database are ideally suited to serve as a template for this
function); 3) gathering and tabulating complete objective
outcome data by a disinterested party (i.e., physicians should
not self-report their results)—ideally, as outcome assessment
standards mature, such data gathering would also include
long-term functional data; 4) oversight and privilege granting
by a physician program director (described below), including
consultation with operators over case selection and procedure
conduct, periodic review of operators’ results and responsibil-
ity for renewal of individual privileges; 5) periodic conferences
at which the laboratory physician staff reviews and analyzes
adverse events; 6) periodic review of the program and physi-
cian quality assessment statistics and comparison of institu-
tional statistics with benchmark rates by the institutional
medical staff leadership.
2. Institutional activity levels. An institution should have an
activity level of at least 400 coronary interventional proce-
dures/year. An institution with ,200 procedures/year, unless in
a geographically underserved region, should carefully consider
whether it should continue to offer the service.
3. Coronary interventional program director. An institution
offering coronary interventional procedures should have a
physician-director who is responsible for the program’s overall
quality. The director should be an experienced operator with a
career experience of .500 procedures. The director should
perform procedures at the facility that he or she directs. The
director should be certified in the commonly used adjunctive
interventional devices and should be certified in interventional
cardiology by the ABIM (once the ABIM Added Qualification
Examination is in place). The program director should assume
responsibility for 1) quality assessment monitoring; 2) main-
taining a mentoring system for less experienced physicians with
a volume of ,75 procedures/year; and 3) maintaining an
optimal working environment in terms of equipment operation
and ancillary support.
4. Facility equipment and staff requirements. The facilities
and staffing requirements for performing coronary interven-
tional procedures have been addressed in detail elsewhere
(63). It is important to emphasize that optimal radiologic
imaging and sophisticated clinical staff support are essential.
Radiologic equipment must provide high resolution fluoro-
scopic imaging with digital video processing to permit readily
immediate review of high quality cinefluorographic images.
The nursing, technical and physician support staff must be
experienced and able to respond readily to emergency and
other unusual situations.
E. Guidelines for Physician-Operators Who Perform
Coronary Interventional Procedures
As outlined in the beginning of this section, the develop-
ment of fair and appropriate standards for judging physician-
operator proficiency presents a complex and difficult challenge.
Intuition and statistical data both support the premise that a
physician who performs coronary interventional procedures
infrequently is unlikely to be as proficient as one who performs
them more often. The low volume operator not only has fewer
opportunities to maintain skills, but is less able to acquire the
additional skill sets needed to become proficient in the use of
new techniques and devices. Furthermore, the low volume
operator is likely to be less experienced at recognizing and
managing procedural complications. Statistical data demon-
strate that operators who perform ,75 procedures/year have
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the highest complication rates. This trend is most pronounced
in institutions with an annual procedural volume ,600 (56).
In view of the above issues, physicians who perform coro-
nary interventional procedures should meet the following
standards:
1. Quality assessment monitoring. A physician-operator’s
proficiency should ultimately be judged by his or her clinical
results. The procedural success and complication rates for all
physician-operators should be rigorously compiled and period-
ically reviewed. The overall performance of physicians whose
complication rates exceed the benchmark standards for any
period should be reviewed by the program director, with
careful attention to statistical power and risk adjustment
issues. Interpretation of complication rates must carefully
consider case-mix. For example, overall benchmark rates may
not apply if an operator’s case-mix includes a disproportionate
fraction of patients with acute MI and cardiogenic shock.
Review of an operator’s performance should be based on
analysis of both current and cumulative quality assessment
statistics. Monitoring of physicians with an annual procedural
volume ,75 should be particularly detailed and careful be-
cause of the difficulty of estimating their true complication rate
and the statistical evidence that these operators, as a group,
have the highest rate of complications.
2. Operator activity levels. An operator should perform
$75 procedures/year to maintain proficiency. Physicians who
perform ,75 procedures/year are at a disadvantage when
attempting to maintain familiarity and competence with the
panoply of currently available interventional techniques or
when required to deal with a complication. Therefore, those
operators who perform 50 to 75 procedures/year should be
very cautious in case selection. Their quality assessment statis-
tics should be carefully reviewed with respect to case selection
and outcome. Ideally, operators with an annual procedural
volume ,75 should work at institutions with an annual proce-
dural volume .600 to have optimal access to mentoring and
backup support.
3. Renewal of privileges. The granting and renewal of
privileges is the responsibility of the governance of the local
health care institution. The privileges of operators whose
complication rates exceed benchmark rates (currently 4% for
combined death and emergency CABG) should be reviewed
carefully, with particular attention to case-mix–based risk
adjustment and statistical power issues. Consideration should
be given to not renewing privileges if an operator’s complica-
tion rate exceeds benchmark rates over a 2-year monitoring
period.
4. Mentoring of operators. Operators who perform ,75
procedures/year should develop a defined mentoring relation-
ship with a highly experienced operator who performs .150
procedures/year. The purpose of this relationship is to ensure
that the operator’s patients can benefit from the skills and
knowledge of a more experienced physician and to facilitate
the operator’s acquisition of additional sophistication and
skills. Elements of this relationship should include 1) consul-
tation with the mentor concerning case selection; 2) scrubbed
assistance by the mentor for complex cases performed primar-
ily by the low volume operator; 3) ready availability of the
mentor to assist in the event of complications; and 4) scrubbing
with the mentor on cases performed primarily by the mentor
for the purpose of gaining additional experience.
Appendix
Standards for Determining an Individual
Physician-Operator’s Case Load
For the purposes of determining an operator’s actual case load, the
following standards should apply. For the purpose of counting the
number of procedures, an interventional procedure is defined as a single
session with a patient in the procedure room, irrespective of how many
or what types of interventions are performed during the session. Only
one physician may claim credit for a particular procedure. A physician-
operator who claims credit for a procedure is the physician in charge
of it. The participation of other physicians is often helpful when
mentoring is needed or so that the additional physician may gain
further experience. In an interventional cardiology fellowship pro-
gram, the trainee will take an active role in the procedure under the
direction of the supervising physician, who is responsible. However,
the attending physician who takes primary responsibility for the
procedure should be credited with performing it.
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